Delivery Order SPE2DX22D0020-SPE2D826F04MC

The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,619.22 to AmerisourceBergen Drug Corp on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. The contract was competitively awarded with no set-aside designation, and performance will take place at the company's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.

Under its broader DLA agreement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical contract enables flexible delivery mechanisms to support military healthcare programs globally, with the agency planning future multiple-award contracts under the Pharmaceutical Prime Vendor Global Program Generation V initiative, which will distribute regional coverage among several contractors.